Shanghai RAAS Blood Products Co., Ltd.
002252
Rank in Stocks
#3635
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Share Price
$0.71007803
Market Cap
$4.68B
Change (1 day)
0.41%
Change (1 year)
-24.40%
Country
CN
Trade Shanghai RAAS Blood Products Co., Ltd. (002252)
Category
Healthcare
Number of shares outstanding for Shanghai RAAS Blood Products Co., Ltd. (002252)
Number of shares outstanding as of June 2026: 6.59B
According to Shanghai RAAS Blood Products Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 6.59B. At the end of December 2023 the company had 6.59B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Shanghai RAAS Blood Products Co., Ltd. (002252) from 2005 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 6.59B | -0.86% |
| 2024 | 6.65B | 0.84% |
| 2023 | 6.59B | -2.23% |
| 2022 | 6.74B | 0.00% |
| 2021 | 6.74B | 0.00% |
| 2020 | 6.74B | 33.07% |
| 2019 | 5.07B | 3.42% |
| 2018 | 4.90B | -0.38% |
| 2017 | 4.92B | 0.58% |
| 2016 | 4.89B | -1.38% |
| 2015 | 4.96B | 18.59% |
| 2014 | 4.18B | 12.08% |
| 2013 | 3.73B | 5.89% |
| 2012 | 3.52B | 0.73% |
| 2011 | 3.50B | -1.10% |
| 2010 | 3.54B | 0.54% |
| 2009 | 3.52B | 14.23% |
| 2008 | 3.08B | 16.19% |
| 2007 | 2.65B | 177.44% |
| 2006 | 954.93M | -0.19% |
| 2005 | 956.76M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | -96.15% |
US
|
|
| 396.00M | -93.99% |
US
|
|
| 478.91M | -92.73% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -99.06% |
NL
|
